Name: PHARMANUTRA SPA (PHN) Stock
Brand: PHARMANUTRA SPA
Rating: 8 (3 reviews)

Question 1

What does PHN do?

Accepted Answer

Pharmanutra SpA develops nutraceutical products and medical devices. The company is headquartered in Pisa, Pisa and currently employs 134 full-time employees. The company went IPO on 2017-07-18. The firm develops nutraceutical products and medical devices. The company focuses on studying and producing formulations that are backed up in scientific research. The company is able to cover all stages of the development of a product, from its design, formulation and registration to its marketing, distribution and training of its commercial representatives. The firm offers Gestalys DHA, a nutritional supplement; Cetilar, a massage coadiuvant, improves and brings relief to joints affected by osteoarthritis; Cetilar patch, a transdermic patch containing a concentrated formulation of cetylated fatty acids (CFA) esters; SiderAL Forte; CardioSiderAL; SiderAL Folico; SiderAL; Bonecal and Novomega, among others.

Question 2

What is the current price of PHN stock?

Accepted Answer

The current stock price of PHN.MI is 56.5 EUR. The price increased by 2.36% in the last trading session.

Question 3

Does PHARMANUTRA SPA pay dividends?

Accepted Answer

PHARMANUTRA SPA (PHN.MI) has a dividend yield of 2%. The yearly dividend amount is currently 0.85.

Question 4

What is the ChartMill technical and fundamental rating of PHN stock?

Accepted Answer

PHN.MI has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 7 out of 10.

Question 5

What is the expected growth for PHN stock?

Accepted Answer

The Revenue of PHARMANUTRA SPA (PHN.MI) is expected  to grow  by 14.06% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.

Question 6

What is the employee count for PHN stock?

Accepted Answer

PHARMANUTRA SPA (PHN.MI) currently has 118 employees.

Question 7

What is PHARMANUTRA SPA worth?

Accepted Answer

PHARMANUTRA SPA (PHN.MI) has a market capitalization of 546.92M EUR. This makes PHN.MI a Small Cap stock.

PHARMANUTRA SPA (PHN.MI) Stock Price, Forecast & Analysis

PHN.MI Latest News, Press Relases and Analysis